| May 5, 2015
| 7:22 PM
Billionaire activist investor William Ackman, who holds a major stake in Trexlertown-based Air Products, came in fourth last year among the top 25 hedge fund managers in the country, according to annual ranking published Tuesday by Institutional Investor'...
| Apr 14, 2015
| 6:35 AM
U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act.
Spending rose 13 percent, the...
| Apr 13, 2015
| 11:22 PM
In a few weeks, the U.S. Supreme Court will hear Glossip vs. Gross, which examines the use of the drug midazolam in lethal injection executions. The case comes on the heels of an infamously gruesome 2014, a year that saw botched executions in Ohio,...
| Apr 7, 2015
| 1:22 PM
The Food and Drug Administration has warned Hospira that corrective actions the drugmaker made at an Italy facility weren't sufficient, the company disclosed Tuesday in a regulatory filing.
The FDA in a March 31 letter said Hospira lacked written...
| Apr 26, 2015
| 5:00 AM
A new crop of specialty drugs holds great promise for treating or even curing some devastating diseases, but their high cost challenges health insurers and taxpayer-funded health programs. In California, Gov. Jerry Brown has asked for $300 million in...
| Apr 30, 2015
| 2:17 PM
Early sales of MannKind Corp.'s new inhaled insulin drug were less than expected, and the Valencia company's stock skidded to near a one-year low.
French pharmaceutical company Sanofi, which is marketing the drug, Afrezza, in a partnership with...
| Apr 29, 2015
| 4:14 PM
The Food and Drug Administration has approved a Westlake Village company's injectable drug as a treatment to reduce double-chin fat in adults.
Kythera Biopharmaceuticals Inc. said in a news release that injections of the drug have been shown in clinical...
| Apr 28, 2015
| 9:00 PM
In one household, a family is devastated by prescription-drug abuse. While in another, a patient can't understand why he is denied the pain medications needed to make life bearable.
Both scenarios are heartbreaking, and different, but also tied...
| Apr 28, 2015
| 7:12 AM
Injectable drugs company Hospira reported first-quarter 2015 results Tuesday that beat expectations. Pharmaceutical giant Pfizer offered to buy the Lake Forest company in February for about $15.23 billion.
Here's a snapshot of the quarter, and a bit...
| Apr 25, 2015
| 11:37 AM
Unregulated drugs produced by controversial compounding pharmacies are costing Connecticut taxpayers up to $24 million this year in prescription payments on behalf of state employees and retirees, a stunning 3,000 percent increase from their $800,000...
| Apr 22, 2015
| 8:25 AM
Health care products and pharmaceuticals company Abbott Laboratories reported first-quarter 2015 results Wednesday marked by two big sales that boosted earnings while beating sales growth.
A snapshot of the quarter, and a bit on what's to come: